ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Global overview 2019 | Trend Analysis & Competition Tracking, Forecast to 2026
ADME is an abbreviation in pharmacokinetics and pharmacology that stands for absorption, distribution, metabolism, and elimination of chemicals and drugs to define impact in the human body. Toxicology testing is a significant event before an introduction of new drugs into the market. However, drug development is very crucial stage of the pharmaceutical and biotechnology manufacturer, as it is attributed to high costs at the various stages of drug development. Thus, one of the key factors linked to the last stage drug failure is inability of new drug candidates to meet human and animal safety profile.
Request a sample copy – ADME (Absorption, Distribution, Metabolism, and Elimination) Toxicology Testing Market report click here: https://www.coherentmarketinsights.com/insight/request-sample/1013
To overcome this barrier of drug failure, ADME toxicology testing has a major advantage to enter in early drug development phase of pre-clinical trials. ADME toxicology testing influence the drug levels and kinetics of drug exposure to the body tissue and hence facilitated the performance in pharmaceutical manufacturing by minimizing drug discovery time, complications in testing, and reduction in overall cost in drug development. Thereby, pre-clinical ADME toxicology testing is a substantial application in drug discovery venture capital (VC) industries to make financial decisions in corresponds to significance and scope in the drug discovery firms. Which is expected to gain more traction of the ADME (absorption, distribution, metabolism, and elimination) toxicology testing market over the forecast period.
Global ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Taxonomy:
On the basis on type of product and technology, global ADME (absorption, distribution, metabolism and elimination) toxicology testing market segmented into:
- Assay Systems
- Software Solutions
- In-silico Testing
- In-vitro Testing
- In-vivo Testing
Quick Buy – ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Research Report: https://www.coherentmarketinsights.com/insight/buy-now/1013
An effort for early-stage drug development by biopharmaceuticals and growing demand for CRO’s advanced ADME toxicology testing are expected to propel the ADME (absorption, distribution, metabolism, and elimination) toxicology testing market
In October, 2014, Wuxi Pharma Tech acquired Xenobiotic Laboratories, Inc. (XBL) to aid its bioanalytical, drug metabolism and pharmacokinetic (DMPK) and ADME (absorption, distribution, metabolism and elimination) services for radio-labeled compounds. Wuxi Pharma Tech’s intends in integrated service portfolio to expand laboratory testing division in North America.
Furthermore, in January, 2014, a specialist ADME-Tox Contract Research Organization (CRO) – Cyprotex PLC entered into an acquisition agreement with an initial financial value of US$ 0.73 million for the business and assets of CeeTox, Inc. The Cyprotex intends to expand the portfolio in in-vitro toxicity assays and screening services to the Cosmetics and Personal Care Industry.
Evotec AG, who offers drug research, development, and its manufacturing services to pharmaceutical company, announced the completion of acquisition with Cyprotex PLC in December, 2016. The deal was designed to enhance Evotec’s ADME-Tox platform, in vitro ADME screening, high-content toxicology screening and mechanistic and, predictive modeling to strengthen its buyer’s drug discovery efforts for an early stage drug development and this deal was closed in US$ 67.6 million. Thereby, is expected to stimulate the ADME (absorption, distribution, metabolism and elimination) toxicology testing market growth over the forecast period.
However, lack of in-vitro models to detect autoimmunity and immune-stimulation are expected to hamper the market growth to some extent.
Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/1013
Increasing demand for cell-based assay by bio-pharmaceutical company is expected to boost the ADME (absorption, distribution, metabolism and elimination) toxicology testing market
Growing adoption of ADME toxicology testing by biotechnology and pharmaceuticals and increasing demand for cell-based assays in drug discovery are major driving factors that are expected to fuel the ADME (absorption, distribution, metabolism and elimination) toxicology testing market growth. For instance, in September, 2017, a leading provider of bio specimens and its related services, BioIVT has announced an acquisition agreement with Qualyst Transporter Solutions, LLC. Qualyst’s cell-based testing approach provides in vitro hepatic models and services which helps in the prediction of the effect of drugs and other compounds in the human liver. Thus, BioIVT enables to predict its new drug impact on the liver. As ADME testing has proven to be an efficient time and cost testing procedures.
Key player in ADME (absorption, distribution, metabolism and elimination) toxicology testing market include Agilent Technologies, Inc., Cellartis AB, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, Inc., Molecular Discovery Ltd, Caliper Life Sciences, Inc., Cyprotex PLC, Optivia Biotechnology, Inc., Promega Corporation, and Beckman Coulter, Inc.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/adme-toxicology-testing-market-1013
Table of Content
Global ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Research Report
Section 1: Global ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Industry Overview
Section 2: Global Economic Impact on ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global ADME (Absorption, Distribution, Metabolism and Elimination) Toxicology Testing Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
- CDN Newswire